Role of hormonal changes in the pathogenesis of osteoporosis in men

Calcified Tissue International

Volumn 75, Issue 2, 2004, Pages 110-113

  Khosla, S ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GROWTH HORMONE; SEX HORMONE; SOMATOMEDIN C; TESTOSTERONE;

AGING; BIOAVAILABILITY; BONE METABOLISM; CONFERENCE PAPER; HORMONE BLOOD LEVEL; HORMONE SYNTHESIS; HUMAN; MALE; OSTEOLYSIS; OSTEOPOROSIS; PATHOGENESIS; PERIOSTEUM; PRIORITY JOURNAL;

AGING; ANDROPAUSE; BONE DENSITY; BONE DEVELOPMENT; FRACTURES, BONE; GONADAL STEROID HORMONES; HUMANS; MALE; OSTEOPOROSIS; RISK FACTORS; SEX HORMONE-BINDING GLOBULIN;

EID: 4444297163     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-004-0290-y     Document Type: Conference Paper

References (28)

1. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB, Korach KS (1994) Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 331:1056-1061
2. Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K (1995) Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 80:3689-3698
3. Carani C, Qin K, Simoni M, Faustini-Fustini M, Serpente S, Boyd J, Korach KS, Simpson ER (1997) Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med 337:91-95
4. Bilezikian JP, Morishima A, Bell J, Grumbach MM (1998) Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. N Engl J Med 339:599-603
5. Falahati-Nini A, Riggs BL, Atkinson EJ, O'Fallon WM, Eastell R, Khosla S (2000) Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest 106:1553-1560
6. Taxel P, Kennedy DG, Fall PM, Willard AK, Clive JM, Raisz LG (2001) The effect of aromatase inhibition on sex steroids, gonadotropins, and markers of bone turnover in older men. J Clin Endocrinol Metab 86:2869-2874
7. Leder BZ, LeBlanc KM, Schoenfeld DA, Eastell R, Finkelstein JS (2003) Differential effects of androgens and estrogens on bone turnover in normal men. J Clin Endocrinol Metab 813:204-210
8. Turner RT, Wakley GK, Hannon KS (1990) Differential effects of androgens on cortical bone histomorphometry in gonadectomized male and female rats. J Orthop Res 8:612-617
9. Khosla S, Melton LJ III, Atkinson EJ, O'Fallon WM, Klee GG, Riggs BL (1998) Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: A key role for bioavailable estrogen. J Clin Endocrinol Metab 83:2266-2274
10. Slemenda CW, Longcope C, Zhou L, Hui SL, Peacock M, Johnston C (1997) Sex steroids and bone mass in older men: positive associations with serum estrogens and negative associations with androgens. J Clin Invest 100:1755-1759
11. Greendale GA, Edelstein S, Barrett-Connor E (1997) Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo study. J Bone Miner Res 12:1833-1843
12. Center JR, Nguyen TV, Sambrook PN, Eisman JA (1999) Hormonal and biochemical parameters in the determination of osteoporosis in elderly men. J Clin Endocrinol Metab 84:3626-3635
13. Ongphiphadhanakul B, Rajatanavin R, Chanprasertyothin S, Piaseau N, Chailurkit L (1998) Serum oestradiol and oestrogen-receptor gene polymorphism are associated with bone mineral density independently of serum testosterone in normal males. Clin Endocrinol 49:803-809
14. Van den Beld AW, de Jong FH, Grobbee DE, Pols HAP, Lamberts SWJ (2000) Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. J Clin Endocrinol Metab 85:3276-3282
15. Amin S, Zhang Y, Sawin CT, Evans SR, Hannan MT, Kiel DP, Wilson PWF, Felson DT (2000) Association of hypogonadism and estradiol levels with bone mineral density in elderly men from the Framingham study. Ann Intern Med 133:951-963
16. Szulc P, Munoz F, Claustrat B, Garnero P, Marchand F (2001) Bioavailable estradiol may be an important determinant of osteoporosis in men: the MINOS study. J Clin Endocrinol Metab 86:192-199
17. Khosla S, Melton LJ III, Atkinson EJ, O'Fallon WM (2001) Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. J Clin Endocrinol Metab 86:3555-3561
18. Seeman E (2002) Pathogenesis of bone fragility in women and men. Lancet 359:1841-1850
19. Pfeilshifter J, Scheidt-Nave C, Leidig-Bruckner G, Woitge WW, Blum WF, Wuster C, Haack D, Ziegler R (1996) Relationship between circulating insulin-like growth factor components and sex hormones in a population-based sample of 50- to 80-year-old men and women. J Clin Endocrinol Metab 81:2534-2540
20. Crave JC, Lejeune H, Brebant C, Baret C, Pugeat M (1995) Differential effects of insulin-like growth factor I on the production of plasma steroid-binding globulins by human hepatoblastoma-derived (HepG2) cells. J Clin Endocrinol Metab 80:1283-1289
21. Bateman TA, Zimmerman RJ, Ayers RA, Ferguson VL, Chapes SK, Simske SJ (1998) Histomorphometric, physical, and mechanical effects of spaceflight and insulin-like growth factor-I on rat long bones. Bone 23:527-535
22. Gillberg P, Johansson AG, Ljunghall (1999) Decreased estradiol levels and free androgen index and elevated sex hormone-binding globulin levels in male idiopathic osteoporosis. Calcif Tissue Int 64:209-213
23. Legrand E, Hedde C, Gallois Y, Degasne I, de Boux Casson F, Mathieu E, Basle MF, Chappard D, Audran M (2001) Osteoporosis in men: A potential role for the sex hormone binding globulin. Bone 29:90-95
24. Evans SF, Davie MWJ (2002) Low body size and elevated sex-hormone binding globulin distinguish men with idiopathic vertebral fracture. Calcif Tissue Int 70:9-15
25. Carlsen CG, Soerensen TH, Eriksen EF (2000) Prevalence of low serum estradiol levels in male osteoporosis. Osteoporosis Int 11:697-701
26. Kurland ES, Rosen CJ, Cosman F, McMahon D, Chan F, Shane E, Lindsay R, Dempster D, Bilezikian JP (1997) Insulin-like growth factor-I in men with idiopathic osteoporosis. J Clin Endocrinol Metab 82:2799-2805
27. Kurland ES, Chan FKW, Rosen CJ, Bilezekian JP (1998) Normal growth hormone secretory reserve in men with idiopathic osteoporosis and reduced circulating levels of insulin-like growth factor-I. J Clin Endocrinol Metab 83:2576-2579
28. Rosen CJ, Kurland ES, Vereault D, Adler RA, Rackoff PJ, Craig WY, Witte S, Rogers J, Bilezikian JP (1998) Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: implications for genetic studies of bone mineral density. J Clin Endocrinol Metab 83:2286-2290